Co-mutation features in treatment-naïve EGFR-mutant lung adenocarcinoma.

e21616Background: In Chinese patients with lung adenocarcinoma, the positive rate of EGFR mutation was 40% - 50%, EGFR-TKIs therapy for lung cancer was also aimed at this part of patients. However,...